Serine/threonine kinase 4 (STK4) inhibition was able to restore DNA-damage mediated apoptosis at baseline or upon treatment with doxorubicin; specific YAP1 activators also induce cell death in MM [38]. The gene discussed is STK4; the disease is Miyoshi myopathy.